SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Logi who wrote (322)8/7/1997 4:12:00 PM
From: Henry Volquardsen   of 1115
 
FWIW I am in this stock for the long term. Assuming all goes well with the phase III lidakol should be able to get into production at least in Europe relatively quickly. If they can go go over the counter that should start generating some decent revenue. I would suspect with a product with the potential of lidakol and enough other irons in the fire that a major would start sniffing around and try to take the company away before we can realize full value. My guess is Bristol-Myers is the most likely candidate with a price in the 20 to 30 dollar range early 99.

Obviously this is just my own guessing but I've been following Lidak since the early 90s and have had a large position at various times. I've loaded up again over the last 9 months and am in no rush to lighten up.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News